Voriconazole (VFEND®, Pfizer) is a triazole antifungal agent used in the treatment of invasive aspergillosis, Candidemia (non-neutropenic) and candidiasis. It is also used to treat serious infections caused by Scedosporium apiospermum and Fusarium spp. including Fusarium solani, in patients intolerant of, or refractory to, other therapy.
The ARK™ Voriconazole II Assay is intended for quantitative determination of voriconazole in human serum. The measurements obtained are used in monitoring levels of voriconazole to help ensure appropriate therapy.
- Convenient, liquid stable, ready-to-use homogeneous enzyme immunoassay that can be run on automated clinical chemistry analyzers
- Wide linear range (0.5 – 16.0 µg/mL), minimizing the need for repeats
ARK™ is a trademark of ARK Diagnostics, Inc.
Calibrator: ARK™ Voriconazole II Calibrator
Control: ARK™ Voriconazole II Control
Product Availability: USA
Sample Type: Serum
Safety Data Sheets
Contact us to get more information, become part of our distribution network, or ask a question about our products and their availability in your region:
|ARK™ Voriconazole II Assay
||R1 1 x 28 mL, R2 1 x 14 mL|